Trial Profile
Randomized, Placebo-controlled, Double-blinded Study of Single Immediate Instillation of EO9 After TURBT in Patients With NMIBC.
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 27 Jun 2019
Price :
$35
*
At a glance
- Drugs Apaziquone (Primary) ; Apaziquone (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- Sponsors Nippon Kayaku
- 01 Apr 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 06 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 Nov 2011 New trial record